GLENMEDE TRUST CO NA - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$212,000
+29.3%
3,982
-0.2%
0.00%0.0%
Q3 2020$164,000
-15.9%
3,988
-1.0%
0.00%0.0%
Q2 2020$195,000
-53.3%
4,028
-58.8%
0.00%
-50.0%
Q1 2020$418,0000.0%9,7810.0%0.00%0.0%
Q4 2019$418,000
+54.8%
9,781
+30.2%
0.00%
+100.0%
Q3 2019$270,000
+280.3%
7,515
+180.4%
0.00%
Q2 2019$71,000
-32.4%
2,680
-31.5%
0.00%
Q1 2019$105,000
+18.0%
3,915
-29.2%
0.00%
Q4 2018$89,000
+6.0%
5,530
+36.4%
0.00%
Q3 2018$84,000
+1300.0%
4,055
+1858.9%
0.00%
Q1 2018$6,0000.0%2070.0%0.00%
Q4 2017$6,000
-14.3%
2070.0%0.00%
Q3 2017$7,000
-50.0%
207
-58.6%
0.00%
Q4 2016$14,000
-6.7%
5000.0%0.00%
Q3 2016$15,000
-16.7%
500
-12.0%
0.00%
Q2 2016$18,000
+20.0%
5680.0%0.00%
Q1 2016$15,000
-11.8%
568
+13.6%
0.00%
Q4 2015$17,000
+6.2%
5000.0%0.00%
Q3 2015$16,000
-20.0%
5000.0%0.00%
Q2 2015$20,000
+25.0%
5000.0%0.00%
Q1 2015$16,000
+6.7%
5000.0%0.00%
Q4 2014$15,000
-37.5%
500
-50.0%
0.00%
Q3 2014$24,000
+9.1%
1,0000.0%0.00%
Q2 2014$22,000
-8.3%
1,0000.0%0.00%
Q1 2014$24,0000.0%1,0000.0%0.00%
Q4 2013$24,000
-11.1%
1,0000.0%0.00%
Q3 2013$27,000
+50.0%
1,0000.0%0.00%
Q2 2013$18,0001,0000.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders